Mid-term outcomes of hemipelvic allograft reconstruction after pelvic bone tumor resections

Basit Öğe Kaydı
dc.contributor.authorKekec, Ahmet Fevzi
dc.contributor.authorGungor, Bedii Safak
dc.date.accessioned2024-02-23T14:41:23Z
dc.date.available2024-02-23T14:41:23Z
dc.date.issued2022
dc.departmentNEÜen_US
dc.description.abstractObjectives: This study aims to evaluate survival of patients and implants, functions, and morbidity of surgical technique of reconstruction with a fresh-frozen massive pelvic allograft following a pelvic resection. Patients and methods: Between January 2009 and December 2016, a total of 19 patients (12 males, 7 females; mean age: 35.8 +/- 14.4 years; range, 10 to 53 years) who underwent reconstruction with fresh-frozen massive allograft after internal hemipelvectomy were retrospectively analyzed. Patients. age, sex, resection types, histopathology and grades, surgical margins, operative times, intraoperative blood loss, complications experienced during their treatment (infection, dislocation, implant failure, nonunion, local recurrence and metastasis), neoadjuvant and adjuvant therapies they received, and functional scores were revelaed and analyzed in 10 years period. Results: According to the Enneking and Dunham classification, two (10%) patients had type I resection only, six (32%) had type I-II, one (5%) had a type II resection, one (5%) had type II-III resection, three (16%) had type I-II-III resection, one (5%) had type I-IV resection, and five (26%) had type I-II-IV resection. The resection involved the acetabulum (type II) in all, but three patients. Several complications were seen in 12 patients, although seven patients had no complication. Pelvic resections had a high mortality rate in patients with malignant tumors and reconstruction with massive allograft had a high morbidity rate with susceptibility to many complications. Prolonged surgical time was found to be directly related to blood loss. Deep infection significantly worsened functional results. Conclusion: Despite the high complication rates seen in pelvic resections, massive pelvic allografts represent a valid option for reconstruction after resection of pelvic tumors, but due to the associated morbidity, patients should be carefully selected.en_US
dc.identifier.doi10.52312/jdrs.2022.344
dc.identifier.endpage131en_US
dc.identifier.issn2687-4784
dc.identifier.issn2687-4792
dc.identifier.issue1en_US
dc.identifier.pmid35361086en_US
dc.identifier.scopus2-s2.0-85127409141en_US
dc.identifier.scopusqualityQ2en_US
dc.identifier.startpage117en_US
dc.identifier.urihttps://doi.org/10.52312/jdrs.2022.344
dc.identifier.urihttps://hdl.handle.net/20.500.12452/16835
dc.identifier.volume33en_US
dc.identifier.wosWOS:000778960800014en_US
dc.identifier.wosqualityQ3en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherTurkish Joint Diseases Foundationen_US
dc.relation.ispartofJoint Diseases And Related Surgeryen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectAllograften_US
dc.subjectHemipelvectomyen_US
dc.subjectPelvic Bonesen_US
dc.subjectSarcomaen_US
dc.subjectTransplantationen_US
dc.titleMid-term outcomes of hemipelvic allograft reconstruction after pelvic bone tumor resectionsen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu